Woodline Partners LP 13F holdings, Q1 2021
Woodline Partners LP disclosed 427 US equity positions worth $4.5bn in its Q1 2021 13F filing. Its largest position is JNJ at 3.8% of the reported book, followed by APH and GILD. Versus Q4 2020 it opened 285 new positions, added to 69, reduced 64 and exited 74.
- $4.5bn
- Reported equity book Sum of the long US equity positions in the filing, at the values filed. Options are excluded.
- 427
- Positions Distinct securities in the equity book with a reported value above zero. Options are excluded.
- 3.8%
- Largest position The largest single position as a share of the reported equity book.
- 19.3%
- Top 10 weight The ten largest positions together, as a share of the reported equity book.
- 117
- Effective positions 1 / HHI of portfolio weights: the number of equal-weight positions the book behaves like.
- 27
- Quarters on file since Q4 2019 Quarters for which this manager's 13F holdings are on record.
Holdings
Against Q4 2020: 285 new, 69 added, 64 reduced, 74 exited
| JNJ JOHNSON & JOHNSON | 3.8% | +85% | added |
| APH AMPHENOL CORP | 2.5% | +133% | added |
| GILD GILEAD SCIENCES INC | 2.2% | – | new |
| DHR DANAHER CORP DEL | 2.0% | +195% | added |
| REGN REGENERON PHARMACEUTICALS | 2.0% | +820% | added |
| FIS FIDELITY NATL INFORMATION SV | 1.6% | −22% | reduced |
| TXN TEXAS INSTRS INC | 1.5% | +9.1% | added |
| EA ELECTRONIC ARTS INC | 1.3% | – | new |
| ZBH ZIMMER BIOMET HOLDINGS INC | 1.2% | +342% | added |
| NVDA NVIDIA CORPORATION | 1.2% | +78% | added |
| ISRG INTUITIVE SURGICAL INC | 1.2% | – | new |
| META META PLATFORMS INC | 1.2% | – | new |
| VSH VISHAY INTERTECHNOLOGY INC | 1.2% | −25% | reduced |
| VOR VOR BIOPHARMA INC | 1.1% | – | new |
| MU MICRON TECHNOLOGY INC | 1.1% | −28% | reduced |
| AMD ADVANCED MICRO DEVICES INC | 1.0% | – | new |
| BKNG BOOKING HOLDINGS INC | 1.0% | – | new |
| QRVO QORVO INC | 1.0% | −21% | reduced |
| VRTX VERTEX PHARMACEUTICALS INC | 1.0% | – | new |
| GPN GLOBAL PMTS INC | 1.0% | −44% | reduced |
| DRNAUSD DICERNA PHARMACEUTICALS INC | 1.0% | +31% | added |
| TGTX TG THERAPEUTICS INC | 1.0% | +2687% | added |
| AGIO AGIOS PHARMACEUTICALS INC | 0.9% | – | new |
| HORIZON THERAPEUTICS PUB L no ticker | 0.9% | +216% | added |
| PAGS PAGSEGURO DIGITAL LTD | 0.9% | – | new |
| TER TERADYNE INC | 0.9% | – | new |
| EBAY EBAY INC. | 0.9% | – | new |
| RVMD REVOLUTION MEDICINES INC | 0.9% | +4.3% | added |
| AERIEUR AERIE PHARMACEUTICALS INC | 0.9% | – | new |
| BMY BRISTOL-MYERS SQUIBB CO | 0.8% | – | new |
| BDX BECTON DICKINSON & CO | 0.8% | −2.3% | reduced |
| MELI MERCADOLIBRE | 0.8% | +40% | added |
| TFX TELEFLEX INCORPORATED | 0.8% | +33% | added |
| RCUS ARCUS BIOSCIENCES INC | 0.8% | – | new |
| CRUS CIRRUS LOGIC INC | 0.8% | +5.6% | added |
| NATIONAL INSTRS CORP no ticker | 0.8% | +160% | added |
| 1K0 IGM BIOSCIENCES INC | 0.7% | −20% | reduced |
| KLAC KLA CORP | 0.7% | +16% | added |
| INTC INTEL CORP | 0.7% | – | new |
| THOMSON REUTERS CORP. no ticker | 0.7% | – | new |
| PINS PINTEREST INC | 0.7% | −12% | reduced |
| CNC CENTENE CORP DEL | 0.7% | – | new |
| COOPER COS INC no ticker | 0.7% | −2.4% | reduced |
| GLUU GLU MOBILE INC | 0.7% | +21% | added |
| VIAV VIAVI SOLUTIONS INC | 0.6% | −2.6% | reduced |
| WAT WATERS CORP | 0.6% | – | new |
| ATVIEUR ACTIVISION BLIZZARD INC | 0.6% | −60% | reduced |
| NTNX NUTANIX INC | 0.6% | +12% | added |
| LYFT LYFT INC | 0.6% | −28% | reduced |
| ALLOVIR INC no ticker | 0.6% | +13% | added |
Exited since Q4 2020
| GOOGL ALPHABET INC | 2.6% | $97.8m |
| MDT Medtronic Plc | 1.8% | $68.7m |
| NXPI NXP SEMICONDUCTORS N V | 1.6% | $61.6m |
| LITE LUMENTUM HLDGS INC | 1.6% | $58.9m |
| TTWO TAKE-TWO INTERACTIVE SOFTWAR | 1.5% | $57.2m |
| MA MASTERCARD INC | 1.4% | $53.7m |
| EXPE EXPEDIA GROUP INC | 1.2% | $45.4m |
| ASML ASML HLDG NV | 1.2% | $45.3m |
| UHS UNIVERSAL HLTH SVCS INC | 1.0% | $39.5m |
| 8IN SYNEOS HEALTH INC | 0.9% | $33.4m |
| CIEN CIENA CORP | 0.8% | $30.3m |
| FOXA FOX CORP | 0.7% | $25.6m |
| NTAP NETAPP INC | 0.7% | $24.8m |
| SENSATA TECHNOLOGIES HLDG PL no ticker | 0.6% | $22.8m |
| OSH3USD OAK STR HEALTH INC | 0.6% | $21.9m |
| ROOT ROOT INC | 0.6% | $21.8m |
| REINVENT TECHNOLOGY PARTNERS no ticker | 0.6% | $21.6m |
| CMCSA COMCAST CORP NEW | 0.5% | $19.6m |
| MPWR MONOLITHIC PWR SYS INC | 0.5% | $19.5m |
| 1LIFE HEALTHCARE INC no ticker | 0.5% | $18.6m |
| DMY TECHNOLOGY GROUP INC III no ticker | 0.4% | $16.6m |
| ILMN ILLUMINA INC | 0.4% | $16.2m |
| OMC OMNICOM GROUP INC | 0.4% | $16.2m |
| CSCO CISCO SYS INC | 0.4% | $14.3m |
| NOVUS THERAPEUTICS INC no ticker | 0.4% | $13.7m |
| PRGO PERRIGO CO PLC | 0.3% | $13.0m |
| QCOM QUALCOMM INC | 0.3% | $13.0m |
| LEGN LEGEND BIOTECH CORP | 0.3% | $12.1m |
| DXCM DEXCOM INC | 0.3% | $12.1m |
| ELAN ELANCO ANIMAL HEALTH INC | 0.3% | $11.8m |
| HUMANCO ACQUISITION CORP no ticker | 0.3% | $11.6m |
| INCY INCYTE CORP | 0.3% | $11.0m |
| LULU LULULEMON ATHLETICA INC | 0.3% | $10.8m |
| CDW CDW CORP | 0.3% | $10.5m |
| KYMR KYMERA THERAPEUTICS INC | 0.3% | $10.5m |
| VIE VIELA BIO INC | 0.3% | $10.2m |
| WST WEST PHARMACEUTICAL SVSC INC | 0.3% | $9.6m |
| OPTU OPTIMUM COMMUNICATIONS INC | 0.2% | $8.7m |
| BOWX ACQUISITION CORP no ticker | 0.2% | $8.3m |
| TRIP TRIPADVISOR INC | 0.2% | $8.1m |
| UAA UNDER ARMOUR INC | 0.2% | $7.3m |
| NYT NEW YORK TIMES CO | 0.2% | $7.3m |
| AKBA AKEBIA THERAPEUTICS INC | 0.2% | $6.7m |
| JNCEEUR JOUNCE THERAPEUTICS INC | 0.2% | $6.6m |
| WEX WEX INC | 0.2% | $6.3m |
| NRIX NURIX THERAPEUTICS INC | 0.1% | $5.3m |
| DIS DISNEY WALT CO | 0.1% | $5.2m |
| GDRX GOODRX HLDGS INC | 0.1% | $4.6m |
| FS DEV CORP no ticker | 0.1% | $4.5m |
| MOTIVE CAPITAL CORP no ticker | 0.1% | $4.2m |
| NVST ENVISTA HOLDINGS CORPORATION | 0.1% | $4.2m |
| ELF E L F BEAUTY INC | 0.10% | $3.7m |
| CERT CERTARA INC | 0.10% | $3.6m |
| LU LUFAX HOLDING LTD | 0.09% | $3.5m |
| ASCENDANT DIGITAL ACQUISITIO no ticker | 0.09% | $3.4m |
| 17 ED & TECHNOLOGY GROUP INC no ticker | 0.09% | $3.4m |
| PG PROCTER & GAMBLE CO | 0.09% | $3.2m |
| CHURCHILL CAPITAL CORP V no ticker | 0.08% | $3.1m |
| THC TENET HEALTHCARE CORP | 0.08% | $3.1m |
| REINVENT TECHNOLOGY PARTNERS no ticker | 0.08% | $3.0m |
| RGNX REGENXBIO INC | 0.06% | $2.2m |
| FHTX FOGHORN THERAPEUTICS INC | 0.06% | $2.1m |
| REPL REPLIMUNE GROUP INC | 0.05% | $2.1m |
| DCPHEUR DECIPHERA PHARMACEUTICALS IN | 0.05% | $2.0m |
| NARIUSD INARI MED INC | 0.05% | $1.9m |
| SNDX SYNDAX PHARMACEUTICALS INC | 0.05% | $1.7m |
| WW6 WW INTL INC | 0.04% | $1.5m |
| DASH DOORDASH INC | 0.04% | $1.4m |
| ACCDUSD ACCOLADE INC | 0.03% | $1.2m |
| BCRX BIOCRYST PHARMACEUTICALS INC | 0.03% | $1.2m |
| REINVENT TECHNOLOGY PARTNERS no ticker | 0.02% | $687k |
| TPG PACE TECH OPPORTUNITIES no ticker | 0.02% | $671k |
| SVRA SAVARA INC | 0.01% | $431k |
| BDSX BIODESIX INC | 0.01% | $231k |
Sector mix
Book over time
Every quarter on file (27)
| Quarter | Positions | Equity book |
|---|---|---|
| Q2 2026 | 1,011 | $32.4bn |
| Q1 2026 | 1,022 | $26.4bn |
| Q4 2025 | 1,009 | $25.8bn |
| Q3 2025 | 870 | $21.2bn |
| Q2 2025 | 911 | $18.9bn |
| Q1 2025 | 891 | $15.4bn |
| Q4 2024 | 916 | $14.8bn |
| Q3 2024 | 584 | $11.8bn |
| Q2 2024 | 542 | $10.4bn |
| Q1 2024 | 525 | $10.8bn |
| Q4 2023 | 464 | $9.2bn |
| Q3 2023 | 580 | $8.5bn |
| Q2 2023 | 615 | $8.4bn |
| Q1 2023 | 618 | $7.1bn |
| Q4 2022 | 742 | $7.3bn |
| Q3 2022 | 738 | $6.8bn |
| Q2 2022 | 791 | $6.1bn |
| Q1 2022 | 708 | $6.0bn |
| Q4 2021 | 693 | $6.8bn |
| Q3 2021 | 671 | $6.0bn |
| Q2 2021 | 586 | $5.4bn |
| Q1 2021 | 427 | $4.5bn |
| Q4 2020 | 216 | $3.8bn |
| Q3 2020 | 178 | $3.1bn |
| Q2 2020 | 147 | $2.5bn |
| Q1 2020 | 136 | $1.4bn |
| Q4 2019 | 105 | $2.4bn |
Where Woodline Partners LP was early
| RCUS ARCUS BIOSCIENCES INC | Q1 2020 | 5 of 99 | 0.10% | Held at last filing, Q2 2026 | +122% |
| RVMD REVOLUTION MEDICINES INC | Q1 2020 | 5 of 164 | 0.09% | Held at last filing, Q2 2026 | +755% |
| VSH VISHAY INTERTECHNOLOGY INC | Q1 2020 | 6 of 134 | 0.8% | Exited by Q2 2026 | +25% |
| ADI ANALOG DEVICES INC | Q1 2020 | 13 of 202 | 2.0% | Held at last filing, Q2 2026 | +343% |
| LYFT LYFT INC | Q1 2020 | 22 of 258 | 0.8% | Exited by Q4 2025 | −18% |
| ALKS ALKERMES PLC | Q2 2020 | 6 of 134 | 1.4% | Held at last filing, Q2 2026 | +170% |
| LEGN LEGEND BIOTECH CORP | Q2 2020 | 6 of 121 | 0.3% | Held at last filing, Q2 2026 | −32% |
| ALLO ALLOGENE THERAPEUTICS INC | Q2 2020 | 8 of 94 | 0.2% | Held at last filing, Q2 2026 | −95% |
| 1K0 IGM BIOSCIENCES INC | Q3 2020 | 5 of 68 | 0.2% | Exited by Q3 2025 | – |
| VOR VOR BIOPHARMA INC | Q1 2021 | 4 of 66 | 1.1% | Held at last filing, Q2 2026 | −98% |
| PR PERMIAN RESOURCES CORP | Q2 2023 | 12 of 143 | 0.8% | Exited by Q1 2026 | +28% |
Concentration and tenure
- 2.8%
- Median largest position, all quarters The largest single position as a share of the reported equity book.
- 15.8%
- Median top 10 weight, all quarters The ten largest positions together, as a share of the reported equity book.
- Diversified
- Style, by median largest position
- 2
- Median completed holding, quarters